Evid Invest
Holders — by stockHoldings — by fund

Propel Bio Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001969764

$188.6M

disclosed book value

30

positions

17.5%

largest position share

Positions, as of 2026-09-30

top 30 of 30 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1PAGPPLAINS GP HOLDINGS LP1.3M$33.0M17.5%
2ACHVACHIEVE LIFE SCIENCES INC3.9M$31.3M16.6%
3DCTHDELCATH SYSTEMS INC604,664$9.7M5.1%
4COLLCOLLEGIUM PHARMACEUTICAL410,175$9.0M4.7%
5CORTCORCEPT THERAPEUTICS INC75,274$8.7M4.6%
6AQSTAQUESTIVE THERAPEUTICS INC278,723$8.6M4.6%
7MISTMILESTONE PHARMACEUTICALS9.4M$8.2M4.3%
8PHATPHATHOM PHARMACEUTICALS I1.1M$8.1M4.3%
9CMPSCOMPASS PATHWAYS PLC549,186$6.8M3.6%
10OBIOORCHESTRA BIOMED HOLDINGS896,701$5.6M3%
11MAZEMAZE THERAPEUTICS INC191,998$5.2M2.8%
12ABEOABEONA THERAPEUTICS INC956,007$5.0M2.7%
13ARTVARTIVA BIOTHERAPEUTICS IN696,436$5.0M2.6%
14KYTXKYVERNA THERAPEUTICS INC700,595$4.8M2.5%
15IVAINVENTIVA SA - ADR1.1M$4.2M2.2%
16CABACABALETTA BIO INC2.0M$3.9M2.1%
17SABSSAB BIOTHERAPEUTICS INC1.2M$3.8M2%
18PROKPROKIDNEY CORP2.0M$3.3M1.8%
19CRVSCORVUS PHARMACEUTICALS INC264,310$3.0M1.6%
20PALIPALISADE BIO INC2.2M$3.0M1.6%
21OCULOCULAR THERAPEUTIX INC357,966$2.7M1.5%
22SCYXSCYNEXIS INC541,474$2.7M1.4%
23FDMT4D MOLECULAR THERAPEUTICS IN179,154$2.6M1.4%
24OVIDOVID THERAPEUTICS INC1.0M$2.5M1.3%
25IMUXIMMUNIC INC236,734$2.2M1.2%
26UPBUPSTREAM BIO INC335,389$1.8M0.9%
27IRDOPUS GENETICS INC270,036$1.3M0.7%
28CLDXCELLDEX THERAPEUTICS INC37,539$1.2M0.6%
29SGPSPYGLASS PHARMA INC41,418$1.1M0.6%
30LONALEONABIO INC149,279$532,9260.3%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.